タンパク質、抗体、アッセイキット
タンパク質カタログ
輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。
- サプライヤー
- TargteMol
- カタログNo.
- TMPY-02234
- 製品名称
- CXCL9 Protein, Human, Recombinant
- タンパク質名
- CXCL9
- Species
- Human
- HOST
- E. coli
- 5μg: -
- お問い合わせ
Overview
Synonyms | MIG, CMK, Humig, chemokine (C-X-C motif) ligand 9, SCYB9, crg-10 |
---|---|
Characteristics | Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first. |
Endotoxin Level | Please contact us for more information. |
Purity | 97.70% |
Description | CXCL9 Protein, Human, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 11.9 kDa and the accession number is Q07325. |
Reference | Colvin RA,et al. (2004) Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. J Biol Chem. 279(29): 30219-27.,Ruehlmann JM,et al. (2001) MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma. Cancer Res. 61(23): 8498-503.,Valbuena G,et al. (2003) Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group. Am J Pathol. 163(4): 1357-69.,Belperio JA,et al. (2003) Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol. 171(9): 4844-52. |
URL | https://www.targetmol.com/recombinant-protein/cxcl9_mig_protein_human_recombinant |